EUROPE NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • EUROPE NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

EUROPE NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

According to world health organization data, 2018, globally, an estimated 300 million people are affected by depression. More women are affected than men. Schizophrenia is a severe mental disorder, affecting about 23 million people worldwide. To treat such disorders, neurostimulation plays a crucial role at a point where medication drugs do not yield as much as it requires.

EUROPE NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

Europe Neurostimulation Device Market by System (Spinal Cord Stimulators (Scs), Deep Brain Stimulators (Dbs), Sacral Nerve Stimulators (Sns), Vagus Nerve Stimulators (Vns), Gastric Electric Stimulator, Other System) by Applications (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Other Applications) by Geography.

Request free sample

According to world health organization data, 2018, globally, an estimated 300 million people are affected by depression. More women are affected than men. Schizophrenia is a severe mental disorder, affecting about 23 million people worldwide. To treat such disorders, neurostimulation plays a crucial role at a point where medication drugs do not yield as much as it requires. The Europe market is proliferating at a CAGR of 9.35% through the forecasting years of 2019-2027.

The supply chain’s major focus is on driving down the costs of neurostimulation devices to increase market revenue in Europe. Chronic pain is one of the major complications in Europe that requires the services of the said market. Clinical evidence of neurostimulation devices compared to other treatment, such as drug therapy is expected to increase during the forecast period. Growing public awareness and the coverage of neurostimulation devices propel market growth in Europe.

The key companies in Europe are Biometrics and Ectron. The market players are implementing several strategic initiatives to ensure the sustainability in this European market. Some of the other major market players are Cogentix Medical Inc., St. Jude Medical Inc. (acquired by Abbott Laboratories), Aleva Neurotherapeutics SA, Boston Scientific Corporation, Helius Medical Technologies, The Magstim Company Limited, Cyberonics Inc., Neuronetics Inc., Depuy Synthes Companies, Ekso Bionics Holding Inc., Medtronic PLC, Dr. Langer Medical GmBH, Ectron Limited, Nevro Corp. and Hocoma AG.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • SPINAL CORD STIMULATORS HOLDS THE LARGEST MARKET SHARE IN TERMS OF NEUROSTIMULATION SYSTEM
      • PAIN MANAGEMENT IS THE MAJORLY USED NEUROSTIMULATION APPLICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • HIGH OCCURRENCE OF NEURO DISEASES
      • DEVELOPMENTS IN TECHNOLOGY
      • RISING DEMAND FOR MINIMALLY INVASIVE SURGERIES
      • HIGH MARKET POTENTIAL FOR SCS DEVICES IN NEUROSTIMULATION
      • INCREASING GERIATRIC POPULATION
      • FAVORABLE REIMBURSEMENT AND INSURANCE APPROVAL POLICIES
    • MARKET RESTRAINTS
      • HIGH PRICE OF NEUROMODULATION TREATMENT
      • SIDE EFFECTS OF ASSOCIATED NEUROSTIMULATION DEVICES
      • ANONYMOUS APPLIANCE OF SCS THERAPY
      • STRINGENT REGULATORY APPROVALS
    • MARKET OPPORTUNITIES
      • DEVELOPMENT OF INDICATION FOR SCS
      • INCREASING THE DEMAND FOR NEUROSTIMULATION DEVICES WITHSTANDING MRI SCANS
      • GROWING OCCURRENCE OF CHRONIC DISCOMFORT
    • MARKET CHALLENGES
      • OBTAINABILITY OF ALTERNATIVE THERAPY
      • SAFETY CONCERNS
  1. MARKET BY SYSTEM
    • SPINAL CORD STIMULATORS (SCS)
    • DEEP BRAIN STIMULATORS (DBS)
    • SACRAL NERVE STIMULATORS (SNS)
    • VAGUS NERVE STIMULATORS (VNS)
    • GASTRIC ELECTRIC STIMULATOR
    • OTHER SYSTEM
  2. MARKET BY APPLICATIONS
    • PAIN MANAGEMENT
    • EPILEPSY
    • ESSENTIAL TREMOR
    • URINARY AND FECAL INCONTINENCE
    • DEPRESSION
    • DYSTONIA
    • GASTROPARESIS
    • PARKINSON’S DISEASE
    • OTHER APPLICATIONS
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF RIVALRY
    • ESTIMATION ANALYSIS
      • INCREASING PREVALENCE OF MENTAL HEALTH PROBLEMS
      • RISING HEALTHCARE EXPENDITURE ACROSS THE GLOBE
      • RISING GERIATRIC POPULATION
    • VALUE CHAIN ANALYSIS
    • PESTLE ANALYSIS
    • OPPORTUNITY MATRIX
  4. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • ALEVA NEUROTHERAPEUTICS SA
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BOSTON SCIENTIFIC CORPORATION
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • COGENTIX MEDICAL INC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • CYBERONICS INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • DEPUY SYNTHES COMPANIES
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • LANGER MEDICAL GMBH
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • ECTRON LIMITED
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • EKSO BIONICS HOLDING INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • HELIUS MEDICAL TECHNOLOGIES
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • HOCOMA AG
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • MEDTRONIC PLC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • NEURONETICS INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • NEVRO CORP
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • JUDE MEDICAL INC. (ACQUIRED BY ABBOTT LABORATORIES)
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • THE MAGSTIM COMPANY LIMITED
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES

TABLES

TABLE  1       EUROPE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

TABLE  2       EUROPE NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)

TABLE  3       EUROPE SPINAL CORD STIMULATORS MARKET 2019-2027 ($ MILLION)

TABLE  4       EUROPE DEEP BRAIN STIMULATORS MARKET 2019-2027 ($ MILLION)

TABLE  5       EUROPE SACRAL NERVE STIMULATORS MARKET 2019-2027 ($ MILLION)

TABLE  6       EUROPE VAGUS NERVE STIMULATORS MARKET 2019-2027 ($ MILLION)

TABLE  7       EUROPE GASTRIC ELECTRIC STIMULATOR MARKET 2019-2027 ($ MILLION)

TABLE  8       EUROPE OTHER SYSTEM MARKET 2019-2027 ($ MILLION)

TABLE  9       EUROPE NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE  10     EUROPE PAIN MANAGEMENT MARKET 2019-2027 ($ MILLION)

TABLE  11     EUROPE EPILEPSY MARKET 2019-2027 ($ MILLION)

TABLE  12     EUROPE ESSENTIAL TREMOR MARKET 2019-2027 ($ MILLION)

TABLE  13     EUROPE URINARY AND FECAL INCONTINENCE  MARKET 2019-2027 ($ MILLION)

TABLE  14     EUROPE DEPRESSION MARKET 2019-2027 ($ MILLION)

TABLE  15     EUROPE DYSTONIA  MARKET 2019-2027 ($ MILLION)

TABLE  16     EUROPE GASTROPARESIS MARKET 2019-2027 ($ MILLION)

TABLE  17     EUROPE PARKINSON’S DISEASE MARKET 2019-2027 ($ MILLION)

TABLE  18     EUROPE OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)

TABLE  19     EUROPE NEUROSTIMULATION DEVICE MARKET BY GEOGRAPHY 2019-2027, (IN $ BILLION)

TABLE  20     EUROPE NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE  1     EUROPE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  2     EUROPE NEUROSTIMULATION DEVICE MARKET SHARE BY SYSTEM 2018 & 2027 (%)

FIGURE  3     EUROPE NEUROSTIMULATION DEVICE MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)

FIGURE  4     EUROPE NEUROSTIMULATION DEVICE MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)

FIGURE  5     EUROPE NEUROSTIMULATION DEVICE MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE  6     EUROPE NEUROSTIMULATION DEVICE MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE  7     EUROPE NEUROSTIMULATION DEVICE MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)

FIGURE  8     EUROPE NEUROSTIMULATION DEVICE MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)

FIGURE  9     EUROPE NEUROSTIMULATION DEVICE MARKET SHARE BY APPLICATIONS 2018 & 2027 (%)

FIGURE  10  EUROPE NEUROSTIMULATION DEVICE MARKET BY PAIN MANAGEMENT 2019-2027 ($ MILLION)

FIGURE  11  EUROPE NEUROSTIMULATION DEVICE MARKET BY EPILEPSY  2019-2027 ($ MILLION)

FIGURE  12  EUROPE NEUROSTIMULATION DEVICE MARKET BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)

FIGURE  13  EUROPE NEUROSTIMULATION DEVICE MARKET BY URINARY AND FECAL INCONTINENCE  2019-2027 ($ MILLION)

FIGURE  14  EUROPE NEUROSTIMULATION DEVICE MARKET BY DEPRESSION 2019-2027 ($ MILLION)

FIGURE  15  EUROPE NEUROSTIMULATION DEVICE MARKET BY DYSTONIA  2019-2027 ($ MILLION)

FIGURE  16  EUROPE NEUROSTIMULATION DEVICE MARKET BY GASTROPARESIS 2019-2027 ($ MILLION)

FIGURE  17  EUROPE NEUROSTIMULATION DEVICE MARKET BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)

FIGURE  18  EUROPE NEUROSTIMULATION DEVICE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)

FIGURE  19  PORTER’S FIVE FORCE MODEL

FIGURE  20  PREVALENCE OF MENTAL HEALTH DISORDERS ACROSS THE GLOBE BETWEEN PERIOD 2012 AND 2020 (MILLION)

FIGURE  21  RISING GERIATRIC POPULATION ACROSS THE GLOBE FOR PERIOD 2014-2020 (MILLION)

FIGURE  22  VALUE CHAIN OF NEUROSTIMULATION DRUGS

FIGURE  23  THE UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  24  FRANCE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  25  GERMANY NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  26  SPAIN NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  27  ITALY NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  28  REST OF EUROPE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE  29  NEUROSTIMULATION DEVICE COMPANY MARKET SHARE 2018 (%)

  1. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
  1. MARKET BY SYSTEM
    • SPINAL CORD STIMULATORS (SCS)
    • DEEP BRAIN STIMULATORS (DBS)
    • SACRAL NERVE STIMULATORS (SNS)
    • VAGUS NERVE STIMULATORS (VNS)
    • GASTRIC ELECTRIC STIMULATOR
    • OTHER SYSTEM
  2. MARKET BY APPLICATIONS
    • PAIN MANAGEMENT
    • EPILEPSY
    • ESSENTIAL TREMOR
    • URINARY AND FECAL INCONTINENCE
    • DEPRESSION
    • DYSTONIA
    • GASTROPARESIS
    • PARKINSON’S DISEASE
    • OTHER APPLICATIONS

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now